New developments in the pharmacodynamics and pharmacokinetics of combination of Chinese medicine and Western medicine

被引:0
|
作者
Di Liu
Xiao-chun Liang
机构
[1] Chinese Academy of Medical Sciences,Department of Traditional Chinese Medicine, Peking Union Medical College Hospital, Peking Union Medical College, Translational Medicine Center
来源
Chinese Journal of Integrative Medicine | 2017年 / 23卷
关键词
combination of Chinese and Western medicine; pharmacodynamics; pharmacokinetics;
D O I
暂无
中图分类号
学科分类号
摘要
It is very common to use Chinese medicine (CM) combined with Western medicine (WM) in clinical practice. The appropriate combination of CM with WM can reduce toxicity and enhance effects in order to make the best use of advantages and bypass the disadvantages. However, an inappropriate combination can not only affect the curative effect but even cause death. Therefore, strengthening the complementary advantages of the CM and WM to improve the therapeutic efficacy and reduce side effects has become an important research topic of clinical medicine and pharmacy. Many researchers try to clarify the effects of combining CM with WM on therapeutic efficacy and absorption, distribution, metabolism and excretion by pharmacodynamics and pharmacokinetics studies, providing evidence for clinical application. This review focuses on the new developments in the pharmacodynamics and pharmacokinetics of the combination of CM with WM in order to give references for clinical treatment.
引用
收藏
页码:312 / 319
页数:7
相关论文
共 50 条
  • [41] Pharmacokinetics, Pharmacodynamics, Tolerability and Safety of Single Doses of Bivalirudin in Healthy Chinese Subjects
    Zhang, Dongmei
    Wang, Zining
    Zhao, Xia
    Lu, Wei
    Gu, Jingkai
    Cui, Yimin
    BIOLOGICAL & PHARMACEUTICAL BULLETIN, 2011, 34 (12) : 1841 - 1848
  • [42] Identification of genetic biomarkers associated with pharmacokinetics and pharmacodynamics of apixaban in Chinese healthy volunteers
    Mu, Guangyan
    Xie, Qiufen
    Liu, Zhiyan
    Zhang, Hanxu
    Meng, Xianmin
    Song, Jinfang
    Zhou, Shuang
    Wang, Zhe
    Wang, Zining
    Zhao, Xia
    Jiang, Jie
    Liao, Maoxing
    Bao, Jiachun
    Zhang, Fan
    Xiang, Qian
    Cui, Yimin
    EXPERT OPINION ON DRUG METABOLISM & TOXICOLOGY, 2023, 19 (01) : 43 - 51
  • [43] A comparison of the pharmacokinetics and pharmacodynamics of cilazapril between Chinese and Caucasian healthy, normotensive volunteers
    Anderson, PJ
    Critchley, JAJH
    Tomlinson, B
    EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY, 1996, 50 (1-2) : 57 - 62
  • [44] Pharmacodynamics, pharmacokinetics, and safety of ticagrelor in Chinese patients with stable coronary artery disease
    Li, Haiyan
    Guo, Jingchuan
    Carlson, Glenn F.
    Teng, Renli
    BRITISH JOURNAL OF CLINICAL PHARMACOLOGY, 2016, 82 (02) : 352 - 361
  • [45] Pharmacology of new oral anticoagulants: mechanism of action, pharmacokinetics, pharmacodynamics
    Masotti, Luca
    Campanini, Mauro
    ITALIAN JOURNAL OF MEDICINE, 2013, 7 : 1 - 7
  • [46] Inhibitory effects of traditional Chinese medicine colquhounia root tablet on the pharmacokinetics of tacrolimus in rats
    Feng, Xiangling
    Shi, Youquan
    Ding, Yufeng
    Zheng, Heng
    JOURNAL OF ETHNOPHARMACOLOGY, 2022, 294
  • [47] Pharmacokinetics and drug delivery systems for puerarin, a bioactive flavone from traditional Chinese medicine
    Zhang, Liang
    DRUG DELIVERY, 2019, 26 (01) : 860 - 869
  • [48] Individualized immunosuppression: new strategies from pharmacokinetics,pharmacodynamics and pharmacogenomics
    Geng Chen and Jia-Hong Dong Army Institute of Hepatobiliary Surgery
    Hepatobiliary & Pancreatic Diseases International, 2005, (03) : 332 - 338
  • [49] Pharmacokinetics and pharmacodynamics of rebamipide. New possibilities of therapy: A review
    Bakulina, Natalia, V
    Tikhonov, Sergey V.
    Okovityi, Sergey, V
    Lutaenko, Elena A.
    Bolshakov, Alexander O.
    Prikhodko, Veronika A.
    Nekrasova, Anna S.
    TERAPEVTICHESKII ARKHIV, 2022, 94 (12) : 1431 - 1437
  • [50] The pharmacokinetics and pharmacodynamics of SGLT2 inhibitors for type 2 diabetes mellitus: the latest developments
    Garcia-Ropero, Alvaro
    Badimon, Juan J.
    Santos-Gallego, Carlos G.
    EXPERT OPINION ON DRUG METABOLISM & TOXICOLOGY, 2018, 14 (12) : 1287 - 1302